Defining response to anti-VEGF therapies in neovascular AMD – (Eye 29, 721 (June 2015))
Defining response to anti-VEGF therapies in neovascular AMD Eye 29, 721 (June 2015). doi:10.1038/eye.2015.48 Authors: W M Amoaku, U Chakravarthy, R Gale, M Gavin, F Ghanchi, J Gibson, S Harding, R L Johnston, S Kelly, A Lotery, S Mahmood, G Menon, S Sivaprasad, J Talks, A Tufail & Y Yang
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients – (Eye 29, 732 (June 2015))
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients Eye 29, 732 (June 2015). doi:10.1038/eye.2015.58 Authors: G A Kim, T H Rim, S C Lee, S H Byeon, H J Koh, S S Kim & C S Lee
The usefulness of the Retinomax autorefractor for childhood screening validated against a Danish preterm cohort examined at the age of 4 years – (Eye 29, 742 (June 2015))
The usefulness of the Retinomax autorefractor for childhood screening validated against a Danish preterm cohort examined at the age of 4 years Eye 29, 742 (June 2015). doi:10.1038/eye.2015.14 Authors: H C Fledelius, R Bangsgaard, C Slidsborg & M laCour
Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland – (Eye 29, 748 (June 2015))
Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland Eye 29, 748 (June 2015). doi:10.1038/eye.2015.20 Authors: S N Chia, H B Smith, H M Hammer & E G Kemp
Comparision of surgical outcomes of intraocular lens refixation and intraocular lens exchange with perfluorocarbon liquid and fibrin glue-assisted sutureless scleral fixation – (Eye 29, 757 (June 2015))
Comparision of surgical outcomes of intraocular lens refixation and intraocular lens exchange with perfluorocarbon liquid and fibrin glue-assisted sutureless scleral fixation Eye 29, 757 (June 2015). doi:10.1038/eye.2015.22 Authors: S Y Oh, S J Lee & J M Park